Expanded Access Program

The HOPE Trial is an Expanded Access Program providing cryopreserved HPC Marrow for urgent allogeneic bone marrow transplant needs

How It Works

From Request to Treatment

Shipped within 3 days of request

Step 01

Email Us

Physician submits a request via email or through our online form.

Step 02

Ship On-Demand

Cryopreserved bone marrow is shipped to the transplant center within days.

Step 03

Transplant

Patient receives the life-saving bone marrow transplant at their center.

Request Information About the HOPE Program

Complete the form below or contact us at [email protected] or (628) 677-4863.

Clinical Scenarios

For Patients Requiring Timely Donor Options

Primary or Secondary Graft Failure

Immediate availability as a rescue option from living donor graft failure, without the delays of re-engaging the donor registry.

Additional Chemo Cycles Not Preferred

When additional rounds of chemotherapy are not a viable path and transplant timing is critical.

Living Donor Falls Through After Conditioning

When a matched donor becomes unavailable after a patient has already begun myeloablative conditioning.

High-Risk MDS/AML

Patients with a narrow treatment window who need flexibility to proceed to transplant when disease status allows.

Rare HLA Types & Poor Match Results (4–6/8)

Patients for whom the unrelated donor pool offers limited or suboptimal matching options.

Severe Aplastic Anemia

Where urgency and the need for adequate cell dose make on-demand, high-dose graft characteristics particularly relevant.